Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
XGN
$7.78
+0.00%
XGN
· Exagen Inc.
$7.78
+0.00 (+0.00%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$187.63M
Shares
24.23M
Volume · Oct 27
180.72K
Avg daily vol (3M)
357.75K
All webcasts
Earnings call · FY2021 Q3
Exagen Inc. (XGN) Q3 2021 Earnings Call
Revenue
$12.25M
Diluted EPS
-$0.42
Gross margin · derived Q4
55.2%
Net income
-$7.18M
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Nov 10, 2021.
| Metric | Period | Guided | Basis | Actual |
|---|---|---|---|---|
|
Revenue
full year 2021
|
$47M – $49M | — | $48.3M within |
SEC filing · Item 2.02
8-K earnings release
Filed Nov 10, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 10, 2021 · complete as-filed document